New cancer clinical trial: Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Duvalumab

Published on: August 31, 2018 at 12:00PM
Condition:   Oesophageal Cancer
Intervention:   Drug: Durvalumab
Sponsors:   Simon C Pacey, MD;   AstraZeneca
Not yet recruiting
https://ift.tt/2opU8ma